{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:17:20Z","timestamp":1792441040900,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ebiom.2025.106083","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:07:40Z","timestamp":1766131660000},"page":"106083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Recommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise"],"prefix":"10.1016","volume":"123","author":[{"given":"Let\u00edcia","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9359-6434","authenticated-orcid":false,"given":"Ezra","family":"Spier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Putrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-3540","authenticated-orcid":false,"given":"Julia Moore","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2025.106083_bib1","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"issue":"20","key":"10.1016\/j.ebiom.2025.106083_bib2","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12941-025-00793-9","article-title":"Long COVID clinical evaluation, research and impact on society: a global expert consensus","volume":"24","author":"Ewing","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.106083_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2024.2007","article-title":"Nirmatrelvir-ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial","author":"Geng","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"0","key":"10.1016\/j.ebiom.2025.106083_bib6","article-title":"Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial","volume":"0","author":"Sawano","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2025.106083_bib9","article-title":"BRIEF\u2014Efgartigimod in PC-POTS is not clinically meaningful","year":"2024","journal-title":"Pharma Lett"},{"issue":"101019","key":"10.1016\/j.ebiom.2025.106083_bib10","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib11","article-title":"Conceptualising the episodic nature of disability among adults living with long COVID: a qualitative study","volume":"8","author":"O'Brien","year":"2023","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ebiom.2025.106083_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2023.1122673","article-title":"Female reproductive health impacts of long COVID and associated illnesses including ME\/CFS, POTS, and connective tissue disorders: a literature review","volume":"4","author":"Pollack","year":"2023","journal-title":"Front Rehabil Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036752","article-title":"Cerebral blood flow in orthostatic intolerance","volume":"14","author":"Khan","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ebiom.2025.106083_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cnp.2020.01.003","article-title":"Cerebral blood flow is reduced in ME\/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography","volume":"5","author":"van Campen","year":"2020","journal-title":"Clin Neurophysiol Pract"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106083_bib46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pmrj.12894","article-title":"Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"14","author":"Blitshteyn","year":"2022","journal-title":"PM R"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2013.9.1.1","article-title":"Autonomic function tests: some clinical applications","volume":"9","author":"Low","year":"2013","journal-title":"J Clin Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diagnostics9010026","article-title":"Assessment of post-exertional malaise (PEM) in patients with myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS): a patient-driven survey","volume":"9","author":"Holtzman","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106083_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10286-019-00598-9","article-title":"Autonomic uprising: the tilt table test in autonomic medicine","volume":"29","author":"Cheshire","year":"2019","journal-title":"Clin Auton Res"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib49","article-title":"COVID-19 induced Postural Orthostatic Tachycardia Syndrome (POTS): a review","volume":"15","author":"Mallick","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ebiom.2025.106083_bib50","series-title":"\u201cIt's like torture\u201d: the tilt table test could be risky for many people with long COVID. The Sick Times - Chronicling the long Covid crisis","author":"Barron","year":"2025"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106083_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/ptj\/pzac005","article-title":"Chronic fatigue and postexertional malaise in people living with long COVID: an observational study","volume":"102","author":"Twomey","year":"2022","journal-title":"Phys Ther"},{"key":"10.1016\/j.ebiom.2025.106083_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fped.2018.00242","article-title":"Cardiopulmonary exercise test methodology for assessing exertion intolerance in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"6","author":"Stevens","year":"2018","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12967-021-02774-w","article-title":"Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME\/CFS","volume":"19","author":"J\u00e4kel","year":"2021","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12967-015-0527-8","article-title":"Submaximal exercise testing with near-infrared spectroscopy in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome patients compared to healthy controls: a case-control study","volume":"13","author":"Miller","year":"2015","journal-title":"J Transl Med"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106083_bib24","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.3390\/jcm9124040","article-title":"The prospects of the two-day cardiopulmonary exercise test (CPET) in ME\/CFS patients: a meta-analysis","volume":"9","author":"Lim","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05410-5","article-title":"Cardiopulmonary and metabolic responses during a 2-day CPET in Myalgic Encephalomyelitis\/Chronic Fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations","volume":"22","author":"Keller","year":"2024","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1479-5876-12-104","article-title":"Inability of myalgic encephalomyelitis\/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment","volume":"12","author":"Keller","year":"2014","journal-title":"J Transl Med"},{"issue":"9S","key":"10.1016\/j.ebiom.2025.106083_bib55","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1249\/01.mss.0000981104.11713.e0","article-title":"Patients with myalgic encephalomyelitis have blunted exercise ventilatory responses in the post-exertional state: 423","volume":"55","author":"Ramos","year":"2023","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/medicina59030571","article-title":"Recovery from exercise in persons with myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"59","author":"Moore","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"101026","key":"10.1016\/j.ebiom.2025.106083_bib57","article-title":"Differences in long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group","volume":"44","author":"Gottlieb","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PHM.0000000000001910","article-title":"Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation","volume":"101","author":"Tabacof","year":"2022","journal-title":"Am J Phys Med Rehabil"},{"issue":"25\u201326","key":"10.1016\/j.ebiom.2025.106083_bib59","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3109\/09638288.2011.582925","article-title":"Reliability and validity of short form 36 version 2 to measure health perceptions in a sub-group of individuals with fatigue","volume":"33","author":"Davenport","year":"2011","journal-title":"Disabil Rehabil"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib60","doi-asserted-by":"crossref","DOI":"10.18061\/dsq.v29i3.938","article-title":"Examining types of fatigue among individuals with ME\/CFS","volume":"29","author":"Jason","year":"2009","journal-title":"Disabil Stud Q"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106083_bib32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.amjmed.2024.04.017","article-title":"Factors associated with long COVID recovery among US adults","volume":"137","author":"Shah","year":"2024","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106083_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s44220-023-00064-6","article-title":"Factors associated with psychiatric outcomes and coping in long COVID","volume":"1","author":"Re\u2019em","year":"2023","journal-title":"Nat Ment Health"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106083_bib62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10456-023-09885-6","article-title":"Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation","volume":"26","author":"Kuchler","year":"2023","journal-title":"Angiogenesis"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106083_bib63","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/bjophthalmol-2021-319450","article-title":"Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID","volume":"106","author":"Bitirgen","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106083_bib64","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.amjmed.2024.10.012","article-title":"Post-acute COVID-19 syndrome: prevalence of peripheral microvascular endothelial dysfunction and associations with NT-ProBNP dynamics","volume":"138","author":"St\u00e5hlberg","year":"2025","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106083_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106297","article-title":"The persistence of Myalgic Encephalomyelitis\/Chronic Fatigue syndrome (ME\/CFS) after SARS-CoV-2 infection: a systematic review and meta-analysis","volume":"89","author":"Dehlia","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2025.106083_bib14","series-title":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness","year":"2015"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols","volume":"11","author":"Carruthers","year":"2003","journal-title":"J Chronic Fatigue Syndr"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106083_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib17","first-page":"33","article-title":"Dissecting the nature of post-exertional malaise","volume":"9","author":"Hartle","year":"2021","journal-title":"Fatigue"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106083_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007004","article-title":"Conceptualising long COVID as an episodic health condition","volume":"6","author":"Brown","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-060826","article-title":"Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with long COVID - protocol for a mixed-methods study","volume":"12","author":"O'Brien","year":"2022","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106083_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197811","article-title":"Deconstructing post-exertional malaise in myalgic encephalomyelitis\/chronic fatigue syndrome: a patient-centered, cross-sectional survey","volume":"13","author":"Chu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.106083_bib21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fneur.2020.01025","article-title":"Characterization of post-exertional malaise in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"11","author":"Stussman","year":"2020","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106083_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/diagnostics8030066","article-title":"A brief questionnaire to assess post-exertional malaise","volume":"8","author":"Cotler","year":"2018","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106083_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1300\/J092v14n02_07","article-title":"Diminished cardiopulmonary capacity during post-exertional malaise","volume":"14","author":"Vanness","year":"2007","journal-title":"J Chronic Fatigue Syndr"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-44432-3","article-title":"Muscle abnormalities worsen after post-exertional malaise in long COVID","volume":"15","author":"Appelman","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.106083_bib31","article-title":"Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study","volume":"33","author":"Mateu","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ebiom.2025.106083_bib29","article-title":"Improvement of long COVID symptoms over one year","volume":"9","author":"Oliveira","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib30","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-022-29513-z","article-title":"Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort","volume":"13","author":"Tran","year":"2022","journal-title":"Nat Commun"},{"issue":"104552","key":"10.1016\/j.ebiom.2025.106083_bib33","article-title":"Cellular and molecular biomarkers of long COVID: a scoping review","volume":"91","author":"Esp\u00edn","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2025.106083_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00411-6","article-title":"Autoantibodies in long COVID: a systematic review","author":"Wilhelm","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2025.106083_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102146","article-title":"Long-term symptom severity and clinical biomarkers in post-COVID-19\/chronic fatigue syndrome: results from a prospective observational cohort","volume":"63","author":"Legler","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106083_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2424","article-title":"Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers","volume":"33","author":"Yong","year":"2023","journal-title":"Rev Med Virol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106083_bib37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/M21-4905","article-title":"A longitudinal study of COVID-19 sequelae and immunity: baseline findings","volume":"175","author":"Sneller","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106083_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400121","article-title":"Distinct plasma immune signatures in ME\/CFS are present early in the course of illness","volume":"1","author":"Hornig","year":"2015","journal-title":"Sci Adv"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106083_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240403","article-title":"Effect of disease duration in a randomized phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"15","author":"Strayer","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106083_bib40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s11136-016-1406-3","article-title":"The utility of patient-reported outcome measures among patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"26","author":"Murdock","year":"2017","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106083_bib41","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/jcm13051369","article-title":"Heterogeneity in measures of illness among patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome is not explained by clinical practice: a study in seven U.S. specialty clinics","volume":"13","author":"Unger","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ebiom.2025.106083_bib42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fped.2018.00330","article-title":"The development of the DePaul symptom questionnaire: original, expanded, brief, and pediatric versions","volume":"6","author":"Jason","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ebiom.2025.106083_bib43","author":"Sommerfelt"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500533X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500533X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T08:24:09Z","timestamp":1768379049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500533X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S235239642500533X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106083","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106083"}}